1171919-75-7 Usage
General Description
2-Chloro-4-iodonicotinonitrile is a specialized chemical compound that features in various scientific and industrial applications. 2-Chloro-4-iodonicotinonitrile, a derivative of nicotinonitrile, is defined by an unique molecular structure that includes two halogens (chlorine and iodine), a cyano group, and is part of the pyridine and nicotinonitrile family. Known for its presence in certain pharmaceutical intermediates, it plays a major role in developing new medicinal products. Besides being used in ongoing scientific research for developing novel drugs, information about its physical properties or potential side effects on humans is not extensively documented since its routine use is not common. Handling this compound requires care because of its reactive nature and should be used under controlled conditions, frequently within a laboratory context.
Check Digit Verification of cas no
The CAS Registry Mumber 1171919-75-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,7,1,9,1 and 9 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1171919-75:
(9*1)+(8*1)+(7*7)+(6*1)+(5*9)+(4*1)+(3*9)+(2*7)+(1*5)=167
167 % 10 = 7
So 1171919-75-7 is a valid CAS Registry Number.
InChI:InChI=1S/C6H2ClIN2/c7-6-4(3-9)5(8)1-2-10-6/h1-2H
1171919-75-7Relevant articles and documents
POLYSUBSTITUTED PYRIDINE COMPOUND, PREPARATION METHOD, USE AND PHARMACEUTICAL COMPOSITION
-
Paragraph 0155-0158, (2017/02/24)
The present invention provides a polysubstituted pyridine compound of Formula I, a preparation method, a use and a pharmaceutical composition thereof. The polysubstituted pyridine compound of Formula I according to the present invention has an excellent anti-tumor effect, can inhibit various cell kinases simultaneously, has significantly excellent pharmacokinetic characteristics, and is very suitable for oral and intravenous administration. The pharmaceutical composition according to the present invention can be useful for treating tumors and cancers.